#D4TS_Picks #GLW — Corning is capitalizing on AI data-center demand through optical fiber, connectivity and hyperscale infrastructure partnerships. Q2 2026 core sales reached $4.74B, up 17% YoY, while core EPS rose 30% to $0.78. Multi-year agreements with Meta, NVIDIA, AT&T and Verizon, alongside ambitious Springboard targets of a $30B annualized sales run rate by 2028, provide significant growth opportunities. Upcoming earnings on October 27, 2026 Resistance: $163.00, $171.00 | Support: $151.50 For Detailed Analysis 👉 https://t.me/c/2454754655/9226 #FRD — Friedman Industries is benefiting from stronger steel prices, rising sales volumes and acquisition-driven expansion. FY2026 revenue grew 46% to $646.9M, while Q1 FY2027 revenue surged 78% YoY to $240M and net income increased to $12.8M. The Century Metals acquisition, Sinton expansion and improved steel-processing capabilities could support further growth Resistance: $43.50, $46.00 | Support: $40.20 For Detailed Analysis 👉 https://t.me/c/2454754655/10382 #PLSE — Pulse Biosciences is advancing its proprietary nPulse™ nanosecond pulsed-field ablation technology for cardiac arrhythmias and benign thyroid nodules. The NANOPULSE-AF pivotal study reached its target of 164 evaluable patients across 15 U.S. sites, while PRECISE-BTN completed enrollment of 100 patients. With $101.6M in cash as of June 30, 2026, upcoming clinical outcomes and regulatory milestones could drive a significant valuation inflection. However, clinical trial failure, cash burn and potential share dilution remain key risks. For Detailed Analysis 👉 https://t.me/c/2454754655/10383 👉 Join our ThinkSabio Stocks WL999 Group To join, simply visit our ThinkSabio Community Page or access the ThinkSabio Bot. 🌐 https://www.thinksabio.com/community D4.jpg